Fundalysisby DARKHORSESTOCKS

Scheme

Nippon India Pharma Fund

Holds 36 companies worth ₹8,919 Cr in Sept 2026.

  • Fund house

    NipponThe fund house that runs this scheme.

  • AUM

    ₹9,166 CrNippon India Pharma Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 3.3% on Aug 2026, ₹9,479 Cr.

  • Largest holding

    Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 11.7% of this scheme's NAV.

  • Fund manager

    Sailesh Raj BhanRuns it since 1 Jun 2004, as the fund house dates it.

Overview(8 Oct 2026)

Fund managers1

  1. Sailesh Raj BhanFund manager · Jun 2004 · 30y · CFA MBA

    Key facts

    Benchmark
    BSE Healthcare TRI
    Risk
    Very High
    Expense
    Regular 1.84% · Direct 1%
    Exit load
    1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units.Nil, thereafter.
    Started
    5 Jun 2004
    Minimum
    ₹5,000

    Source.Its Scheme Summary Document as of 8 Oct 2026 at AMFI.

    What changed(17 changes)

    Oct 2026

    1 change
    1. Expense ratio
      8 OctDirect 0.99% → 1%

    Sept 2026

    1 change
    1. Category
      9 SeptEquity: Sectoral/Thematic Funds → Sectoral Fund

    Aug 2026

    1 change
    1. Expense ratio
      23 AugRegular 1.85% → 1.84%Direct 1% → 0.99%

    Source.Its filings at NSE, since Aug 2024.

    Fund managers over time(Jun 2004 – now)

    1. Sailesh Raj Bhan
    MainCoSlice200520092013201720212025
    Fig. 1.Who ran it when: each manager from the date the fund house gives, or the first document listing them where it gives none, to when they left. A slice is part of it: overseas, gold and silver, or arbitrage.

    Costs(Aug 2024 – Oct 2026)

    Every change to the expense ratio, newest first.
    17 changesRegularDirectΔ pt
    8 Oct 20261.84%1.00%0.01
    23 Aug 20261.84%0.99%0.01
    9 Jul 20261.85%1.00%0.01
    9 Jun 20261.85%0.99%0.06
    14 May 20261.78%0.93%0.01
    7 May 20261.78%0.94%0.01
    9 Apr 20261.80%0.95%0.03
    8 Jan 20261.82%0.92%0.01
    9 Dec 20251.81%0.91%0.02
    10 Jun 20251.80%0.89%0.02
    10 Apr 20251.82%0.91%0.01
    10 Feb 20251.81%0.92%0.01
    10 Jan 20251.80%0.91%0
    11 Nov 20241.81%0.91%0.02
    10 Oct 20241.79%0.89%0.02
    20 Sept 20241.81%0.91%0.01
    20 Aug 20241.80%0.90%–
    Direct plan, 8 Oct 2026
    1.00%
    Regular plan 1.84% · Exit load 1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units.Nil, thereafter.
    Fig. 1.Total expense ratio a year, each plan's, as its Scheme Summary Documents state it, filing by filing at NSE. A change holds until the next.

    Objective and risk(8 Oct 2026)

    Objective

    The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. There is no assurance that the investment objective of the Scheme will be achieved.

    Risk, type and benchmark

    Riskometer
    Very High
    At launch
    High
    Type
    Open
    Benchmark
    BSE Healthcare TRI

    Asset allocation it may hold% of NAV

    1. Equity and Equity related Instruments of companies in Pharma Sector –
      Allowed80–100%
    2. Equity and Equity Related securities of companies other than those engaged in pharma sector
      Allowed0–20%
    3. Debt Securities & Money Market instruments
      Allowed0–20%Holds2.7%
    4. Units issued by REITs and InvITs –
      Allowed0–10%Holds0.0%

    Holds in Sept 2026.97.3% equity · 2.7% debt and cash

    How to invest(8 Oct 2026)

    Buying

    To start
    ₹5,000, then in multiples of ₹1
    To add
    ₹1,000, then in multiples of ₹1
    Most
    Any
    Systematic
    SIP - Monthly, Quarterly, Yearly SWP - Monthly / Quarterly / Half yearly / Yearly STP - Daily/ Weekly/ Fortnightly/ Monthly / Quarterly
    Dates
    SIP - 1st to 31st of a month SWP - 1st, 8th, 15th, 22nd transaction day (if holiday, then next working day) STP - 1st to 28th of a month
    Minimum
    SIP - Rs.100/- per month (minimum 60 months) Rs.500/- per month (minimum 12 months) Rs.1000/- per month (minimum 6 months) Rs. 500/- per quarter (minimum 12 quarters) Rs.1500/- per quarter (minimum 4 quarters) Rs. 5000/- per year (minimum 2 years) SWP - 500 STP - Daily- Minimum of Rs. 100 Weekly / Fortnight / Monthly option - Rs. 1000 Quarterly - Rs. 3000 Capital Appreciation Monthly/ Quarterly - Rs. 500, then sIP - Rs. 500 if SIP amount is 5,000 per year & Rs. 1 for any other amount SWP - 1 STP - 1
    Instalments
    SIP - 60 months for Rs. 100 per month 12 months for Rs. 500 per month 6 months for Rs. 1,000 per month 12 quarters for Rs. 500 per quarter 4 quarters for Rs. 1500 per quarter 2 years for Rs. 5000 per Year SWP - 2 STP - 2
    Most
    SIP - Any SWP - Any STP - Any

    Selling and switching

    To redeem
    ₹100 or Any units
    Switch minimum
    ₹5,000

    Scheme details(8 Oct 2026)

    What it is

    Category
    Sectoral Fund
    Offer
    10 May 2004 to 26 May 2004
    Started
    5 Jun 2004
    Reopened
    8 Jun 2004
    Plans
    Direct Growth Plan Bonus Option Bonus · Direct Plan IDCW Plan Payout · Direct Plan IDCW Plan Reinvestment · Direct Plan Growth Plan - Growth Option Growth · Growth Plan Bonus Option Bonus · IDCW Plan Payout · IDCW Plan Reinvestment · Growth Plan - Growth Option Growth
    Face value
    ₹10
    Listed
    No

    How it is run

    Swing pricing
    No
    Side-pocketing
    No
    Custodian
    Deutsche Bank
    Auditor
    Walker Chandiok & Co LLP
    Registrar
    KFin Technologies Limited
    SEBI code
    NIMF/O/E/SEC/04/02/0014